Malaria Research and Treatment / 2013 / Article / Tab 1

Clinical Study

Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

Table 1

Study participant’s characteristics at enrolment.

CharacteristicAS/AQ ( )AL ( ) value

Sex
 Male39 (53.4)39 (50.6)0.73
 Female34 (46.6)38 (49.4)
Age (years)
 Mean ± SD 0.98
 Range01.0–13.001.0–13.0
Weight (kg)
 Mean ± SD 0.52
 Range07.0–41.006.0–35.0
Temperature (°C)
 Mean ± SD 0.80
 Range31.1–40.535.5–39.8
Haemoglobin (g/dL)
 Mean ± SD 0.55
 Range4.8–28.04.9–17.8
Anaemia
 (Hb < 9.5 g/dL)21/73 (28.8)26/77 (33.8)0.51
Parasitaemia (/μL)
 GMPD4628.303886.360.18
 Range1340–184 0001240–156 000

SD: standard deviation, GMPD: geometric mean parasite density, and numbers in brackets represent percentages. There were no significant differences between baseline characteristics for participants randomised in both treatment arms.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.